State-of-the-art Clinical Facilities

Inquiries

Volunteer lenexa

We provide end-to-end bioanalytical support from Pre-Clinical to Phase IV studies.

At PRA, our clinics are managed, staffed, and supported by industry-leading experts who have the scientific knowledge and experience to successfully deliver even the most complex of studies.

Our clinics

We operate state-of-the-art facilities in the Netherlands and North America, as well as an innovative patient pharmacology model in Central and Eastern Europe. In addition, our laboratory facilities are situated close to our clinical facilities and configured to support all study requirements.

Lenexa, Kansas, USA

From First-in-Human to Proof-of-Concept programs, we can help take your product from concept to compound to cure.

Our strategically located, state-of-the-art clinical research center in Lenexa, Kansas has 114 patient beds and a GMP-practicing pharmacy. We can handle all types of formulations in our temperature- and humidity-controlled setting and our co-located bioanalytical laboratory ensures rapid sample processing for critical, dose-escalation, and decision-making involving pharmacokinetic assays.

We have extensive experience in:

  • Focused First-in-Human studies through Proof-of-Concept
  • Vaccine studies

Salt Lake City, Utah, USA

We’re shaping the future of clinical research at our state-of-the-art Phase I Clinic in Salt Lake City, Utah.

Our 136-bed Salt Lake City clinic was custom-built for First-in-Human and early phase studies in healthy volunteers and patients. We are strategically located across the street from a trauma hospital and can fully support timely, efficient data collection while always ensuring the safety of each study participant. We also provide dedicated patient wards, private dosing rooms, and flexible space to accommodate your rigorous assessment needs.

Our meticulously designed investigative unit supports the precise execution of all early phase clinical trials. Although we’re capable of conducting studies across all therapeutic areas, we have a particular focus in CNS with neurology and psychiatry specialization, analgesia, abuse liability, and sleep medicine.

Groningen, the Netherlands

From First-in-Human to Proof-of-Concept programs, we can help take your product from concept to compound to cure.

Our 150-bed Clinical Pharmacology Unit in Groningen, the Netherlands is strategically located and directly connected to the Martini Hospital, including direct access to their intensive care unit. This partnership ensures we have access to the latest tools, technology, and expertise, including:

We have extensive experience in:

  • First-in-Human studies
  • Positron emission tomography (PET)
  • Functional magnetic resonance imaging (fMRI) scans
  • Cerebral spinal fluid (CSF) sampling
  • Validated pain models
  • Cognitive testing
  • Spirometry
  • ADME studies

Budapest, Hungary

Providing accessible Phase I solutions throughout Hungary.

Our Budapest clinic focuses on oncological, ADME, and mass balance studies, as well as rheumatology and renal impairment studies. As one of only 14 accredited Phase I units in Hungary, our centrally-located clinic is easily accessible to patients and is within close proximity of additional hospital services if required. We’ve also developed excellent working relationships with university clinics and top institutions throughout the region to ensure we provide the safest, most effective solutions.

Prague, Czech Republic

Conducting safe, effective Phase I and II studies.

Based in Prague, Czech Republic, we conduct clinical trials on pharmaceuticals, pharmacokinetics, and pharmacodynamics of investigational products. We primarily focus on Phase I and II studies that utilize special patient populations with renal and hepatic diseases, diabetes, and rheumatoid arthritis.

Curious to learn more about our capabilities?

Read more

Explore related content and topics

Strategies for Accelerating Rare Disease Clinical Development White Paper

Strategies for Accelerating Rare Disease Clinical Development

Rare disease trials differ from those in most other therapeutic areas because the indications are more complex and involve smaller patient…

View Resource
Strong Site Selection Leads To Success Case Study

Strong Site Selection Leads To Success

A randomized, double-blind, placebo-controlled Phase III study of Study Drug versus placebo for patients with advanced gastrointestinal stromal…

View Resource
Data Services Page

Data Services

Every day we’re making breakthroughs in how we use data to answer questions, but we’re also making breakthroughs in how our data is empowering our…

Read More

View all related content and resources for Patient Recruitment and Retention

Explore Insights